Temi della conferenza There's currently a lot of exciting news circulating about the progress of genetic therapies targeting blood disorders.
As more and more promising results emerge from various clinical 3 trials, it's essential that this industry comes together to share knowledge, optimize trial design and discuss strategies for commercial launch.
Speakers: Gabriela Denning, Vice President, Research and Development, Expression Therapeutics, Clark Paramore, Head of Value Demonstration, Vice President HEOR, bluebird bio, and more.
Quote del Congresso Conference Only Industry - Early Rate: USD 1499.00,
Conference Only Industry - Standard Rate: USD 1999.00,
Conference Only Academic - Early Rate: USD 1199.00,
Conference Only Academic - Standard Rate: USD 1799.00
Contatto organizzatori 83 Great Titchfield Street W1W 6RH London United Kingdom